1064nm laser

DEVICE3 trials

Sponsors

Cynosure, Inc., David Weinstein, Massachusetts General Hospital

Conditions

Cutaneous LupusCutaneous NeurofibromaSubcutaneous Fat

Phase 1

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

CompletedNCT04730583

Massachusetts General HospitalCutaneous Neurofibroma

Start: 2021-06-02End: 2024-04-19Updated: 2025-02-21

Unknown Phase

Evaluation of the Safety and Precursors of Efficacy

CompletedNCT02098811

Cynosure, Inc.Subcutaneous Fat

Start: 2013-06-30End: 2014-05-31Updated: 2020-10-27

Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

TerminatedNCT03639857

David WeinsteinCutaneous Lupus

Start: 2018-08-17End: 2019-12-31Updated: 2021-07-21